AETHLON MEDICAL, INC. Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31)
AETHLON MEDICAL, INC. (AEMD) reported Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) of 0.02% for the 12-month period ending 2014-03-31, per its 10-K filed 2015-07-13.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsRiskFreeInterestRate · last filed 2015-07-13
- AETHLON MEDICAL, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2012-06-30 was 0.60%.
- AETHLON MEDICAL, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2014 was 0.02%, a 60.00% decline from fiscal 2013.
- AETHLON MEDICAL, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2013 was 0.05%.
| Period end | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 3 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 6 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 9 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 12 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|
| 2014-03-31 | 0.02% 10-K · filed 2015-07-13 | ||||
| 2013-03-31 | 0.05% 10-K · filed 2014-07-15 | 1.44% 10-K · filed 2013-07-15 | |||
| 2012-12-31 | 1.44% 10-Q · filed 2013-02-12 | ||||
| 2012-09-30 | 1.44% 10-Q · filed 2012-11-13 | ||||
| 2012-06-30 | 0.60% 10-Q/A · filed 2012-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |